Nontherapeutic Risk Factors of Different Grouped Stage IIIC Breast Cancer Patients’ Mortality: A Study of the US Surveillance, Epidemiology, and End Results Database
Table 5
Predictors of DSS in patients with different N3 stages.
Factor
N3a (n = 1426) AUC (95% CI)
N3b (n = 166) AUC (95% CI)
N3c (n = 81) AUC (95% CI)
χ 2
value
ER status
0.5925 (0.566∼0.619)
≤0.001
0.6176 (0.535∼0.700)
0.020
0.5186 (0.409∼0.628)
0.775
2.09
0.3525
PR status
0.6136 (0.585∼0.642)
≤0.001
0.6143 (0.532∼0.697)
0.024
0.5425 (0.434∼0.652)
0.514
1.54
0.4636
Molecular typing
0.5813 (0.551∼0.612)
≤0.001
0.6327 (0.542∼0.723)
0.009
0.4783 (0.355∼0.602)
0.745
3.90
0.1420
T stage
0.5689 (0.536∼0.602)
≤0.001
0.6365 (0.541∼0.732)
0.007
0.5941 (0.470∼0.718)
0.149
1.79
0.4088
LNP
0.5604 (0.531∼0.590)
≤0.001
0.5352 (0.472∼0.598)
0.495
0.4981 (0.401∼0.596)
0.977
1.76
0.4146
LNR
0.5797 (0.551∼0.609)
≤0.001
0.5119 (0.441∼0.583)
0.814
0.5730 (0.467∼0.679)
0.260
2.99
0.2238
AUC: area under the curve. CI: confidence interval. DSS: disease-specific survival. ER: estrogen receptor. LNP: positive lymph nodes. LNR: lymph node ratio. PR: progesterone receptor.
